ADVENZYMES: Q2 consolidated profit rose YoY as revenue advanced; the buyback closed at 99.99% of its cap
NiveshIQ
NSE: ADVENZYMES · Healthcare
Advanced Enzyme Tech Ltd.
₹281.45▲ ₹17.90 (+6.79%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on ADVENZYMES. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Advanced Enzyme Tech Ltd.
Advanced Enzyme Technologies Limited (ADVENZYMES) operates in the basic materials sector, focusing on the research, development, manufacture, and marketing of a broad portfolio of enzymes and probiotics across India, Europe, the United States, and Asia. Its core revenue drivers include specialty enzymes such as serratiopeptidase, lactase, peptizyme SP, and nattokinase, as well as probiotics for human and animal nutrition, serving food processing, textile, leather, pulp and paper, and detergent markets. In FY27 Q2, the company reported revenue of ₹2,145 million and a net income of ₹171 million, while the first half of FY27 saw revenue rise to ₹4,062 million, indicating robust growth momentum. ADVENZYMES completed a share buyback of 2,410,906 shares, closing at 99.99% of its market capitaliz
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹623.87 Cr +15.39% | ₹636.91 Cr +2.09% | ₹745.76 Cr +17.09% |
| EBITDA Margin | 32.77% | 30.53% | 30.72% |
| Net Profit | ₹133.31 Cr +26.19% | ₹131.12 Cr -1.64% | ₹168.72 Cr +28.68% |
| EPS | ₹11.92 | ₹11.72 | ₹15.08 |
Annual figures in Indian Rupees (Crores). Source: company filings (NSE).
Recent News
Advanced Enzyme Technologies Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026
Advanced Enzyme Technologies reports ₹2,145 million revenue in Q2 FY27
🔒
+ 3 more stories about Advanced Enzyme Tech Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q2FY27 results: revenue ₹215 Cr, PAT ₹48 Cr, EPS ₹4.33, EBITDA margin 33.6%. Growth context: revenue YoY +16.2%, PAT YoY +11.5%, revenue QoQ +13.0%, PAT QoQ +30.2%.
Realisations, demand recovery, cost efficiency, capacity utilisation, and margin discipline remain the key forward drive...
FY26 (last completed FY): revenue ₹746 Cr, PAT ₹169 Cr, EBITDA margin 30.7%, EPS ₹15.08. Year-on-year: revenue YoY +17.1...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantMore Healthcare stocks
Yatharth Hospital & Trauma Care Services Ltd.Zydus Lifesciences Ltd.Aarti Drugs Ltd.Aarti Pharmalabs Ltd.Abbott India Ltd.Acutaas Chemicals Ltd.Ajanta Pharmaceuticals Ltd.Akums Drugs and Pharmaceuticals Ltd.Alembic Pharmaceuticals Ltd.Alivus Life Sciences Ltd.Alkem Laboratories Ltd.Anthem Biosciences Ltd.
Everything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for ADVENZYMES
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track ADVENZYMES alongside your other holdings
Unlock full ADVENZYMES research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Advanced Enzyme Tech Ltd.?
NiveshIQ detects active intelligence signals for Advanced Enzyme Tech Ltd. (ADVENZYMES) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Advanced Enzyme Tech Ltd.?
Advanced Enzyme Tech Ltd. operates in the Healthcare sector with a market capitalisation of ₹404,895.2L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.